Cardiovascular Disease Related News
Tackling cardiovascular disease in Europe
Laurent Abuaf, SVP and President Europe at Amarin, outlines the social and economic burden of CVD in Europe and the company’s key priorities for...
Eating multiple sources of protein may lower blood pressure risk
A Chinese study has found that eating a balanced diet comprised of various sources of protein is potentially effective at reducing the risk of...
Cardiovascular disease risk not reduced by high vegetable consumption
A new collaborative study suggests that consuming a diet rich in vegetables does not lower cardiovascular disease risk.
Performed by researchers from the Nuffield Department...
Could daily exercise prevent major heart disease in old age?
Research suggests that 20 minutes of daily exercise in early old age (70-75 years old) may best prevent major heart disease, including heart failure,...
Amarin: Changing the landscape of residual cardiovascular disease risk
World-leading pioneers of the pharmaceutical industry, Amarin Corporation, comprehensively explore the ever-evolving landscape of cardiovascular disease, analysing the current challenges facing mitigating the impacts...
CVD management: Getting to the heart of the matter
Professor Hugo Katus and Ms Christina Dimopoulou of the European Society of Cardiology discuss the key challenges in cardiovascular disease prevention and care.
Cardiovascular disease...
Elevated heart rate linked to increased risk of dementia
An elevated heart rate in old age could be a risk factor of dementia, according to a study at Karolinska Institutet in Sweden published...
The link between processed foods and the risk of second heart attacks or strokes
A new study shows that the high consumption of industrially processed foods significantly increases the risk of second heart attacks or fatal strokes in...
Sleep schedule discovered to impact heart health significantly
A research team in the UK has identified the optimal time window for sleep that maximises heart health, finding that deviating from this sleep...
Pioneering research reveals how liver fat affects heart health
A groundbreaking study conducted by researchers at AMRA Medical has identified the impacts that varying visceral and liver fat levels can have on cardiometabolic...
Viagra shown to suppress abnormal heart rhythms
The drug sildenafil, sold under the brand name Viagra, can strongly suppress abnormal heart rhythms, a new study has found.
In a study led by...
Drones could increase survival chances for cardiac arrest patients, study suggests
In a first-of-its-kind pilot project, drones have proved successful in delivering defibrillators to cardiac emergencies.
The study, carried out by Karolinska Institutet in Sweden, found...
Myogenic tone analysis uncovers mechanisms behind heart disease
The poor myogenic tone in micro-arteries may be a significant cause of unexplained heart disease, a new study has found.
The research, led by Professor...
Statin use reduced risk of cancer in heart failure patients
Statin use can lessen the risk of cancer and mortality in heart failure patients, new research has found.
Academics at the University of Hong Kong...
Sleep apnoea in heart disease patients underrecognised and undertreated
Obstructive sleep apnea occurs in 40% to 80% of people with cardiovascular disease, however, new research has shown that it is often underrecognised and...
MHRA gives green light to cardiovascular treatment
The Medicines and Healthcare products Regulatory Agency has authorised Vazkepa to reduce cardiovascular risk in statin-treated adult patients who have elevated triglycerides and other...
Scientists create most detailed 3D scan of congenital heart disease
Scientists have created the most detailed 3D heart scan of a rare form of congenital heart disease.
The team at the University of Manchester have...
Breakthrough to target care for deadly hypertrophic cardiomyopathy
Researchers have made a groundbreaking discovery of new genetic faults in patients living with the deadly heart condition hypertrophic cardiomyopathy (HCM) which could help...
Reducing cardiovascular and cerebrovascular deaths with AstraZeneca
AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as...
World Heart Day: preventing heart disease is vital
Today (29 September) marks World Heart Day, and new findings from the European Society of Cardiology shows that preventing heart disease could save billions...
